Nutritional treatments for acute myocardial infarction

Alternative Medicine Review

Volumn 15, Issue 2, 2010, Pages 113-123

  Gaby, Alan R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CARNITINE; MAGNESIUM SULFATE; OXYGEN; PLACEBO; UBIDECARENONE; VITAMIN B GROUP; MAGNESIUM; UBIQUINONE; VITAMIN B COMPLEX;

ACUTE HEART INFARCTION; CELL METABOLISM; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFECT; ENERGY; HEART MUSCLE; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; METABOLIC DISORDER; MORTALITY; NONHUMAN; NUTRIENT; OXIDATIVE STRESS; REPERFUSION INJURY; REVIEW; ANALOGS AND DERIVATIVES; DIET SUPPLEMENTATION; DRUG EFFECTS; MYOCARDIAL INFARCTION; PRIMARY PREVENTION; PROCEDURES; UNITED STATES;

ANTIOXIDANTS; ASCORBIC ACID; CARNITINE; DIETARY SUPPLEMENTS; HUMANS; MAGNESIUM; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PRIMARY PREVENTION; UBIQUINONE; UNITED STATES; VITAMIN B COMPLEX; VITAMIN E;

EID: 77954642417     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (74)

1. Raab W. The nonvascular metabolic myocardial vulnerability factor in "coronary heart disease." Fundamentals of pathogenesis, treatment, and prevention. Am Heart J 1963;66:685-706.
2. Baroldi G. Coronary heart disease: significance of the morphologic lesions. Am Heart J 1973;85:1-5.
3. Baroldi G. Acute coronary occlusion as a cause of myocardial infarct and sudden coronary heart death. Am J Cardiol 1965;16:859-880.
4. Erhardt LR, Unge G, Boman G. Formation of coronary arterial thrombi in relation to onset of necrosis in acute myocardial infarction in man. A clinical and autoradiographic study. Am Heart J 1976;91:592-598.
5. Reichenbach DD, Moss NS. Myocardial cell necrosis and sudden death in humans. Circulation 1975;52:11160-11162.
6. Silver MD, Anderson TW, Vand Dreumel AA, Hutson RE. Letter: Nutritional muscular dystrophy and human myocardial infarction. Lancet 1973;2:912-913.
7. Robin ED. Special report: dysoxia. Abnormal tissue oxygen utilization. Arch Intern Med 1977;137:905-910.
8. Shechter M, Merz CN, Paul-Labrador M, et al. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Am J Cardiol 1999;84:152-156. (Pubitemid 29331330)
9. Turlapaty PD, Altura BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 1980;208:198-200.
10. Henrotte JG. Type A behavior and magnesium metabolism. Magnesium 1986;5:201-210.
11. Seelig MS. Consequences of magnesium deficiency on the enhancement of stress reactions; preventive and therapeutic implications (a review). J Am Coll Nutr 1994;13:429-446.
12. Seelig MS, Heggtveit HA. Magnesium interrelationships in ischemic heart disease: a review. Am J Clin Nutr 1974;27:59-79.
13. Heggtveit HA, Herman L, Mishra RK. Cardiac necrosis and calcification in experimental magnesium deficiency. A light and electron microscopic study. Am J Pathol 1964;45:757-782.
14. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J 1984;108:188-193.
15. Vasku J, Urbanek E, Nevrtal M. The influence of K-Mg-aspartate upon the incidence and development of non-specific cardiac necroses in the young albino rat. Exp Med Surg 1966;24:210-219.
16. Vormann J, Fischer G, Classen HG, Thoni H. Influence of decreased and increased magnesium supply on the cardiotoxic effects of epinephrine in rats. Arzneimittelforschung 1983;33:205-210.
17. Chang C, Varghese PJ, Downey J, Bloom S. Magnesium deficiency and myocardial infarct size in the dog. J Am Coll Cardiol 1985;5:280-289. (Pubitemid 15174083)
18. Ravn HB, Moeldrup U, Brookes CI, et al. Intravenous magnesium reduces infarct size after ischemia/reperfusion injury combined with a thrombogenic lesion in the left anterior descending artery. Arterioscler Thromb Vasc Biol 1999;19:569-574. (Pubitemid 29135157)
19. Bajusz E, Selye H. The chemical prevention of cardiac necroses following occlusion of coronary vessels. Can Med Assoc J 1960;82:212-213.
20. Kanther R. Compensation of hypoxia in the human heart muscle by means of potassium magnesium aspartate. In: Bajusz E, ed. Electrolytes and Cardiovascular Diseases, Volume 2. Basel, Switzerland: S. Karger; 1966:324-328.
21. Rasmussen HS, McNair P, Goransson L, et al. Magnesium deficiency in patients with ischemic heart disease with and without acute myocardial infarction uncovered by an intravenous loading test. Arch Intern Med 1988;148:329-332. (Pubitemid 18064810)
22. Dyckner T. Serum magnesium in acute myocardial infarction. Relation to arrhythmias. Acta Med Scand 1980;207:59-66.
23. Parsons RS, Butler T, Sellars EP. The treatment of coronary artery disease with parenteral magnesium sulphate. Med Proc 1959;5:487-498.
24. Malkiel-Shapiro B. Further observations on parenteral magnesium sulphate therapy in coronary heart disease: a clinical appraisal. S Afr Med J 1958;32:1211-1215.
25. Malkiel-Shapiro B, Bersohn I, Terner PE. Parenteral magnesium sulphate therapy in coronary heart disease. A preliminary report on its clinical and laboratory aspects. Med Proc 1956;2:455-462.
26. Rasmussen HS, McNair P, Norregard P, et al. Intravenous magnesium in acute myocardial infarction. Lancet 1986;1:234-236. (Pubitemid 16132851)
27. Gyamlani G, Parikh C, Kulkarni AG. Benefits of magnesium in acute myocardial infarction: timing is crucial. Am Heart J 2000;139:703.
28. Shechter M, Hod H, Marks N, et al. Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol 1990;66:271-274.
29. Shechter M, Hod H, Chouraqui P, et al. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol 1995;75:321-323.
30. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992;339:1553-1558.
31. Smith LF, Heagerty AM, Bing RF, Barnett DB. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality. Int J Cardiol 1986;12:175-183.
32. Thogersen AM, Johnson O, Wester PO. Effects of intravenous magnesium sulphate in suspected acute myocardial infarction on acute arrhythmias and long-term outcome. Int J Cardiol 1995;49:143-151.
33. Abraham AS, Rosenmann D, Kramer M, et al. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med 1987;147:753-755.
34. Abraham AS, Balkin J, Rosenmann D, et al. Continuous intravenous infusion of magnesium sulfate after acute myocardial infarction. Magnes Trace Elem 1990;9:137-142.
35. Friedman HS. Magnesium therapy of angina pectoris, myocardial infarction and congestive heart failure. Magnes Trace Elem 1990;9:318.
36. Antman EM. Randomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story. Am J Cardiol 1995;75:391-393.
37. Teo KK, Yusuf S. Role of magnesium in reducing mortality in acute myocardial infarction. A review of the evidence. Drugs 1993;46:347-359.
38. Shechter M, Hod H, Rabinowitz B, et al. Long-term outcome of intravenous magnesium therapy in thrombolysis-ineligible acute myocardial infarction patients. Cardiology 2003;99:205-210.
39. Nakashima H, Katayama T, Honda Y, et al. Cardioprotective effects of magnesium sulfate in patients undergoing primary coronary angioplasty for acute myocardial infarction. Circ J 2004;68:23-28.
40. Feldstedt M, Boesgaard S, Bouchelouche P, et al. Magnesium substitution in acute ischaemic heart syndromes. Eur Heart J 1991;12:1215-1218.
41. Magnesium in Coronaries (MAGIC) Trial Investigators. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial. Lancet 2002;360:1189-1196.
42. No authors listed. ISIS-4: a randomised factorial trial assessing early oral Captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995;345:669-685.
43. Seelig MS, Elin RJ, Antman EM. Magnesium in acute myocardial infarction: still an open question. Can J Cardiol 1998;14:745-749.
44. Seelig MS, Elin RJ. Reexamination of magnesium infusions in myocardial infarction. Am J Cardiol 1995;76:172-173.
45. Seelig MS, Elin RJ. Is there a place for magnesium in the treatment of acute myocardial infarction? Am Heart J 1996;132:471-477.
46. Stevenson RN, Keywood C, Amadi AA, et al. Angiotensin converting enzyme inhibitors and magnesium conservation in patients with congestive cardiac failure. Br Heart J 1991;66:19-21.
47. Sushamakumari S, Jayadeep A, Kumar JS, Menon VP. Effect of carnitine on malondialdehyde, taurine and glutathione levels in heart of rats subjected to myocardial stress by isoproterenol. Indian J Exp Biol 1989;27:134-137. (Pubitemid 19086763)
48. Spagnoli LG, Corsi M, Villaschi S, et al. Myocardial carnitine deficiency in acute myocardial infarction. Lancet 1982;1:1419-1420.
49. Xue YZ, Wang LX, Liu HZ, et al. L-carnitine as an adjunct therapy to percutaneous coronary intervention for non-ST elevation myocardial infarction. Cardiovasc Drugs Ther 2007;21:445-448. (Pubitemid 350231510)
50. Rizzon P, Biasco G, Di Biase M, et al. High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects. Eur Heart J 1989;10:502-508. (Pubitemid 19183787)
51. Tarantini G, Scrutinio D, Bruzzi P, et al. Metabolic treatment with L-carnitine in acute anterior ST segment elevation myocardial infarction. A randomized controlled trial. Cardiology 2006;106:215-223.
52. Iliceto S, Scrutinio D, Bruzzi P, et al. Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) trial. J Am Coll Cardiol 1995;26:380-387.
53. Corbucci GG, Loche F. L-carnitine in cardiogenic shock therapy: pharmacodynamic aspects and clinical data. Int J Clin Pharmacol Res 1993;13:87-91. (Pubitemid 24038911)
54. Weitz ZW, Birnbaum AJ, Sobotka PA, et al. High breath pentane concentrations during acute myocardial infarction. Lancet 1991;337:933-935.
55. Loeper J, Goy J, Rozensztajn L, et al. Lipid peroxidation and protective enzymes during myocardial infarction. Clin Chim Acta 1991;196:119-125.
56. Davies SW, Ranjadayalan K, Wickens DG, et al. Lipid peroxidation associated with successful thrombolysis. Lancet 1990;335:741-743.
57. Hume R, Weyers E, Rowan T, et al. Leucocyte ascorbic acid levels after acute myocardial infarction. Br Heart J 1972;34:238-243.
58. Machtey I, Syrkis I, Fried M. Studies of blood ascorbic acid levels in acute myocardial infarction. Clin Chim Acta 1975;62:149-151.
59. Axford-Gately RA, Wilson GJ. Myocardial infarct size reduction by single high dose or repeated low dose vitamin E supplementation in rabbits. Can J Cardiol 1993;9:94-98.
60. Axford-Gatley RA, Wilson GJ. Reduction of experimental myocardial infarct size by oral administration of alpha-tocopherol. Cardiovasc Res 1991;25:89-92.
61. Sebbag L, Forrat R, Canet E, et al. Effects of dietary supplementation with alpha-tocopherol on myocardial infarct size and ventricular arrhythmias in a dog model of ischemia-reperfusion. J Am Coll Cardiol 1994;24:1580-1585.
62. Klein HH, Pich S, Lindert S, et al. Combined treatment with vitamins E and C in experimental myocardial infarction in pigs. Am Heart J 1989;118:667-673.
63. Chamiec T, Herbaczynska-Cedro K, Ceremuzynski L. Effects of antioxidant vitamins C and E on signal-averaged electrocardiogram in acute myocardial infarction. Am J Cardiol 1996;77:237-241.
64. Jaxa-Chamiec T, Bednarz B, Drozdowska D, et al. Antioxidant effects of combined vitamins C and E in acute myocardial infarction. The randomized, double-blind, placebo controlled, multicenter pilot Myocardial Infarction and VITamins (MIVIT) trial. Kardiol Pol 2005;62:344-350.
65. Jaxa-Chamiec T, Bednarz B, Herbaczynska-Cedro K, et al. Effects of vitamins C and E on the outcome after acute myocardial infarction in diabetics: a retrospective, hypothesis-generating analysis from the MIVIT study. Cardiology 2009;112:219-223.
66. Huang HY, Appel LJ. Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr 2003;133:3137-3140.
67. Christen S, Woodall AA, Shigenaga MK, et al. Gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications. Proc Natl Acad Sci USA 1997;94:3217-3222.
68. Hensley K, Williamson KS, Floyd RA. Measurement of 3-nitrotyrosine and 5-nitro-gamma-tocopherol by high-performance liquid chromatography with electrochemical detection. Free Radic Biol Med 2000;28:520-528.
69. Jiang Q, Christen S, Shigenaga MK, Ames BN. Gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 2001;74:714-722. (Pubitemid 33101790)
70. Saldeen T, Li D, Mehta JL. Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol 1999;34:1208-1215. (Pubitemid 29500562)
71. Murray ED Jr, Wechter WJ, Kantoci D, et al. Endogenous natriuretic factors 7: biospecificity of a natriuretic gamma-tocopherol metabolite LLU-alpha. J Pharmacol Exp Ther 1997;282:657-662. (Pubitemid 27340164)
72. Vermaak WJ, Barnard HC, Potgieter GM, Marx JD. Plasma pyridoxal-5′-phosphate levels in myocardial infarction. S Afr Med J 1986;70:195-196. (Pubitemid 16015124)
73. Vermaak WJ, Barnard HC, Potgieter GM, Theron HD. Vitamin B6 and coronary artery disease. Epidemiological observations and case studies. Atherosclerosis 1987;63:235-238.
74. Kagiyama A, Ogura R, Ueta H. Depletion of riboflavin contents in subsarcolemmal and intermyofibrillar mitochondria of canine heart muscle affected by ischemia. J Clin Biochem Nutr 1991;11:41-45.